AGIO R&D to Revenue
Agios Pharmaceuticals Inc · R&D to Revenue
AGIO R&D to Revenue
Latest reported225.17%period ending
AGIO Quarterly R&D/Revenue (152.38% → 225.17%)
Latest values, visible window
High-resolution chart · PNG
AGIO r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 225.1738% | |
| 384.5802% | |
| 434.6672% | |
| 663.2143% | |
| 728.069% | |
| 818.9892% | |
| 771.7614% | |
| 808.2887% | |
| 879.9536% | |
| 821.4922% | |
| 1,071.1812% | |
| 1,106.1089% | |
| 999.5232% | |
| 1,167.9622% | |
| 1,588.9559% | |
| 1,791.3823% | |
| 1,294.0165% | |
| 8,130.4087% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 217.3731% | |
| 258.039% | |
| 243.4386% | |
| 104.7739% | |
| 299.7968% | |
| 390.6855% | |
| 409.5534% | |
| 316.2239% | |
| 312.5612% | |
| 543.236% | |
| 214.6039% | |
| 892.7642% | |
| 787.9988% | |
| 641.988% | |
| 703.4726% | |
| 596.9928% | |
| 285.5793% | |
| 674.936% | |
| 728.0596% | |
| 140.7819% | |
| 593.9691% | |
| 657.4453% | |
| 275.5352% | |
| 94.857% | |
| 238.2003% | |
| 75.2979% | |
| 268.4104% | |
| 206.9552% | |
| 226.5569% | |
| 236.1678% | |
| 206.7326% | |
| 182.8653% | |
| 178.6851% | |
| 156.3178% | |
| 166.3963% | |
| 152.3772% |